Finance
Finance
HomeZEAL • CPH
Zealand Pharma A/S
kr 426.00
Aug 22, 11:17:47 AM GMT+2 · DKK · CPH · Disclaimer
StockDK listed security
Previous close
kr 411.60
Day range
kr 410.70 - kr 427.20
Year range
kr 306.10 - kr 930.00
Market cap
29.14B DKK
Avg Volume
362.77K
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Financials
Income Statement
Revenue
Net income
(DKK)Jun 2025Y/Y change
Revenue
9.09B26,527.65%
Operating expense
749.45M156.38%
Net income
7.57B2,687.07%
Net profit margin
83.33109.72%
Earnings per share
105.612,361.46%
EBITDA
8.34B3,298.22%
Effective tax rate
6.62%
Total assets
Total liabilities
(DKK)Jun 2025Y/Y change
Cash and short-term investments
16.58B85.59%
Total assets
17.18B69.17%
Total liabilities
1.57B106.88%
Total equity
15.61B
Shares outstanding
70.38M
Price to book
1.86
Return on assets
158.51%
Return on capital
168.73%
Net change in cash
(DKK)Jun 2025Y/Y change
Net income
7.57B2,687.07%
Cash from operations
8.52B3,782.77%
Cash from investing
-1.57B-5,074.21%
Cash from financing
-309.75M-104.59%
Net change in cash
6.47B-0.23%
Free cash flow
5.95B2,247.55%
About
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Founded
Apr 1, 1997
Employees
424
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu